NCT03117738View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 9, 2017

Primary Completion Date

June 26, 2019

Study Completion Date

August 31, 2019

Conditions
Alzheimer Disease
Interventions
DRUG

AstroStem

Autologous adipose tissue derived mesenchymal stem cells (AdMSC)

OTHER

Placebo-Control

Saline with 30% auto-serum

Trial Locations (3)

92626

ATP Clinical Research, Costa Mesa

92705

Syrentis Clinical Research, Santa Ana

96817

Valden Medical, Honolulu

All Listed Sponsors
lead

Nature Cell Co. Ltd.

INDUSTRY

NCT03117738 - A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter